Pharmacyclics' (PCYC) Imbruvica Seen Pricing Higher in Germany - Analyst

Pricing of Pharmacyclics' (Nasdaq: PCYC) Imbruvica might be seeing a higher price across the pond.

Wedbush noted today that Imbruvica might sell for €8,387 per 90-pill bottle in Germany, compared with $8,200 per bottle in the U.S. That's an unusual pricing scheme, the firm noted.

Wedbush cites an October 22 Apotheke adhoc article on the report. The article is written in German, which means it might take tome to filter through as not many buy- or sell-siders speak the language.

Shares of Pharmacyclics are up 3.4 percent.

You May Also Be Interested In

• AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab
• W.R. Berkley (WRB) PT Lowered to $85 at Evercore ISI
• Boston Beer Company (SAM) PT Lowered to $325 at Jefferies